Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.48 USD
Change Today +0.0039 / 0.83%
Volume 412.9K
IMUC On Other Exchanges
As of 11:48 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John Boockvar M.D.

Member of Scientific Advisory Board, ImmunoCellular Therapeutics, Ltd.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 3 different industries.

See Board Relationships


Dr. John Boockvar, M.D. heads the Brain Tumor and Stem Cell Research Laboratory at Weill Cornell Medical College and directs the institution's Brain Tumor Research Group. Dr. Boockvar's laboratory interests have focused on studying adult human neural stem cell biology to investigate brain tumor formation and brain tumor and stem cell migration and survival. Dr. Boockvar served as Editor-in-Chief of the journal Current Stem Cell Research and Therapy and is an editorial ...

Read Full Background

Corporate Headquarters*

23622 Calabasas Road
Calabasas, California 91302

United States

Phone: 818-264-2300
Fax: 818-224-5287

Board Members Memberships*

There is no Board Members Memberships data available.


The University of Pennsylvania

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMUC:US $0.48 USD +0.0039


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOCELLULAR THERAPEUTICS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at